It is, therefore, interesting that ABCB1-overexpressing, doxorubicin-resistant canine mammary cancer [15] and human osteosarcoma cells [40] relied on multiple resistance mechanisms, as they also showed cross-resistance to platinum-based agents. This evidence concerns the gene ABCB1 and breast cancer.